Laboratory Corp of America Holdings Company News


02 May, 2024 @ 06:22 by Yahoo! Finance

On April 29, 2024, Peter Wilkinson, Senior Vice President and Chief Accounting Officer at Laboratory Corp of America Holdings (NYSE:LH), sold 2,439 shares of the company.

Insightful Analysis of LH's Market Position and Future Prospects

Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript April 25, 2024 Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.68, expectations were $3.46. Laboratory Corporation of America Holdings isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details […]

The board of Laboratory Corporation of America Holdings ( NYSE:LH ) has announced that it will pay a dividend on the...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the U.S. Food and Drug Administration (FDA) has approved its nAbCyte™ Anti-AAVRh74var HB-FE Assay, a companion diagnostic (CDx) to determine patient eligibility for treatment with BEQVEZ™ (fidanacogene elaparvovec-dzkt), Pfizer's recently FDA-approved hemophilia B gene therapy.

Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.

26 Apr, 2024 @ 15:30 by Yahoo! Finance

Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.

Laboratory Corporation of America Holdings ( NYSE:LH ) First Quarter 2024 Results Key Financial Results Revenue...

Q1 2024 Laboratory Corporation of America Holdings Earnings Call

25 Apr, 2024 @ 17:11 by Yahoo! Finance

William Blair analyst Andrew Brackmann said Labcorp is being aggressive in its M&A strategy, after announcing last month it would buy several of Bioreference Health’s testing businesses.

Old Arcived News About Laboratory Corp of America Holdings

  • 3 Stocks Underperforming Today In The Health Services Industry.
  • 8:46 am Laboratory Corp agrees to acquire the operating assets of Pathology; terms not disclosed.
  • Advanced Animal Diagnostics Closes $15 Million in Oversubscribed Series C Funding. [PR Newswire] - DURHAM, N.C., Dec. 8, 2014 /PRNewswire/ -- Advanced Animal Diagnostics (AAD) announced today the close of a $15 million Series C round of equity financing. The financing was co-led by Cultivian Sandbox ...
  • Barbarian At The Gate: Laboratory Corp Of America Hldgs (LH).
  • Bet on these 3 winning outperformers: Pro.
  • Diagnosing Theranos.
  • Final Trade: BorgWarner, Yum, Morgan Stanley & more.
  • Insider Trading Alert - CWT, LH And RHT Traded By Insiders.
  • Insider Trading Alert - OHAI, CELP And LH Traded By Insiders.
  • Is Xilinx, Inc..
  • LabCorp (LH) Stock Up on Mixed Q4 Results.
  • LabCorp Announces Acquisition of Bode Technology. [at noodls] - Acquisition expands LabCorp's forensic DNA testing and relationship analysis capabilities BURLINGTON, N.C.--(BUSINESS WIRE)--Dec. 5, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: ...
  • LabCorp Buys DNA Testing Firm, Expands Forensics Business.
  • LabCorp Enters into Definitive Agreement to Acquire Assets of Pathology, Inc.. [at noodls] - BURLINGTON, N.C.--(BUSINESS WIRE)--Dec. 10, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that it has entered into a definitive agreement to acquire substantially ...
  • LabCorp Introduces a Test to Identify Enterovirus D-68. [at noodls] - BURLINGTON, N.C.--(BUSINESS WIRE)--Dec. 18, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of a reflex test to identify enterovirus D68 (EV-D68), ...
  • LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68). [at noodls] - BURLINGTON, N.C.--(BUSINESS WIRE)--Dec. 18, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of a reflex test to identify enterovirus D68 (EV-D68), ...
  • LabCorp is Scheduled to Present at the 2015 Credit Suisse Healthcare Conference. [at noodls] - BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 3, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the 2015 Credit Suisse Healthcare Conference. ...
  • LabCorp Launches New Enhanced Report for Medical Drug Monitoring. [at noodls] - The LabCorp MedWatch ® ToxAssure ® report joins a suite of proprietary decision support tools to assist clinicians in patient management BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 30, 2015-- Laboratory Corporation ...
  • LabCorp Named Laboratory Service Provider of the Pro Football Legends. [at noodls] - MOUNT LAUREL, N.J. & BURLINGTON, N.C.--(BUSINESS WIRE)--Dec. 17, 2014-- Pro Football Legends, the commercial marketing arm of the National Football League Alumni, Inc. (NFL Alumni) and Laboratory Corporation ...
  • LabCorp reportedly pursuing purchase of $1B UK-based testing firm.
  • Laboratory Corp Of America Holdings (LH) Earnings Report: Q4 2015 Conference Call Transcript.
  • LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Entry into a Material Definitive Agreement.
  • LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD Disclosure.
  • LABORATORY CORP OF AMERICA HOLDINGS Financials.
  • Theranos Fails to Deliver as Safeway Deal Unravels.
  • Water-Logged And Getting Wetter: Laboratory Corp Of America Hldgs (LH).

Laboratory Corp of America Holdings Short Company Overview:

Laboratory Corporation of America Holdings is a clinical laboratory company that offers clinical laboratory tests used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. The Company develops specialty testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical trials.